11/14/2024
8:00 PM | Nurix Therapeutics (Subject)
Redmile Group, LLC (Filed by)
| Form SC 13G/A | |
11/14/2024
11:48 AM | Nurix Therapeutics (Subject)
WASATCH ADVISORS LP (Filed by)
| Form SC 13G/A | |
11/08/2024
9:52 AM | Nurix Therapeutics (Subject)
WELLINGTON MANAGEMENT GROUP LLP (Filed by)
| Form SC 13G | |
11/07/2024
4:37 PM | MORGAN STANLEY (Filed by)
Nurix Therapeutics (Subject)
| Form SC 13G/A | |
11/04/2024
4:48 PM | Nurix Therapeutics (Issuer)
Ring Christine (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/01/2024
4:57 PM | Nurix Therapeutics (Issuer)
van Houte Hans (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/01/2024
4:57 PM | Nurix Therapeutics (Issuer)
Ring Christine (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
|
11/01/2024
3:50 PM | Nurix Therapeutics (Subject)
van Houte Hans (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
11/01/2024
3:41 PM | Nurix Therapeutics (Subject)
Ring Christine (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
10/31/2024
3:36 PM | Nurix Therapeutics (Filer)
| Form 424B5 | |
10/31/2024
3:12 PM | Nurix Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/31/2024
3:01 PM | Nurix Therapeutics (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
10/30/2024
7:30 PM | Nurix Therapeutics (Issuer)
Ring Christine (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/30/2024
7:30 PM | Hansen Gwenn (Reporting)
Nurix Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/30/2024
7:30 PM | Nurix Therapeutics (Issuer)
van Houte Hans (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/16/2024
3:41 PM | Nurix Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/16/2024
3:47 PM | Kapur Anil (Reporting)
Nurix Therapeutics (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
10/16/2024
3:48 PM | Kapur Anil (Reporting)
Nurix Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/15/2024
8:16 AM | Nurix Therapeutics (Issuer)
Ring Christine (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/11/2024
3:05 PM | Nurix Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
10/01/2024
6:36 PM | Nurix Therapeutics (Issuer)
Ring Christine (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/01/2024
3:32 PM | Nurix Therapeutics (Subject)
Ring Christine (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
09/05/2024
6:01 AM | Nurix Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/03/2024
4:33 PM | Nurix Therapeutics (Issuer)
Ring Christine (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/03/2024
3:28 PM | Nurix Therapeutics (Subject)
Ring Christine (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
08/26/2024
5:23 PM | Nurix Therapeutics (Issuer)
Ring Christine (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/26/2024
4:41 PM | Nurix Therapeutics (Issuer)
van Houte Hans (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/26/2024
3:24 PM | Nurix Therapeutics (Subject)
Ring Christine (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
08/26/2024
3:25 PM | Nurix Therapeutics (Subject)
van Houte Hans (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
08/01/2024
6:06 PM | Nurix Therapeutics (Issuer)
Ring Christine (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/01/2024
6:06 PM | Nurix Therapeutics (Issuer)
van Houte Hans (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/01/2024
3:31 PM | Nurix Therapeutics (Subject)
van Houte Hans (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
07/30/2024
6:06 PM | Nurix Therapeutics (Issuer)
van Houte Hans (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/30/2024
6:06 PM | Nurix Therapeutics (Issuer)
Ring Christine (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/30/2024
6:06 PM | Hansen Gwenn (Reporting)
Nurix Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/18/2024
3:06 PM | Kunkel Lori Anne (Reporting)
Nurix Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/11/2024
3:45 PM | Nurix Therapeutics (Filer)
| Form 424B5 | |
07/01/2024
5:35 PM | Nurix Therapeutics (Issuer)
Ring Christine (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/20/2024
2:23 PM | Nurix Therapeutics (Subject)
van Houte Hans (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
06/17/2024
6:02 AM | Nurix Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/13/2024
5:39 PM | Nurix Therapeutics (Issuer)
Nurix Therapeutics (Issuer)
Ring Christine (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
Unveiled: NVIDIA’s "Secret Royalty" Program (Ad) Did you know that there's an investment that will give you the opportunity to collect "royalties" every time Nvidia makes a chip? Click Here to learn how to get in now >>> |
06/12/2024
6:30 PM | Nurix Therapeutics (Issuer)
Ring Christine (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/07/2024
12:30 PM | BlackRock Inc. (Filed by)
Nurix Therapeutics (Subject)
| Form SC 13G/A | |
06/05/2024
5:01 PM | Nurix Therapeutics (Issuer)
Ring Christine (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/03/2024
5:36 PM | Nurix Therapeutics (Issuer)
Ring Christine (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/21/2024
6:06 AM | Nurix Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/20/2024
6:25 PM | Nurix Therapeutics (Issuer)
Saltzman Edward C (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/20/2024
6:25 PM | Nurix Therapeutics (Issuer)
Reinsdorf Judith A (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/20/2024
6:25 PM | Lacey David L. (Reporting)
Nurix Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/20/2024
6:25 PM | GREGORY JULIA P (Reporting)
Nurix Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/20/2024
6:26 PM | Kunkel Lori Anne (Reporting)
Nurix Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/20/2024
6:26 PM | Nurix Therapeutics (Issuer)
Silva Paul M (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/02/2024
5:01 PM | Nurix Therapeutics (Issuer)
van Houte Hans (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/02/2024
3:19 PM | Nurix Therapeutics (Subject)
van Houte Hans (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
04/30/2024
5:33 PM | Nurix Therapeutics (Issuer)
Ring Christine (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/30/2024
5:33 PM | Hansen Gwenn (Reporting)
Nurix Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/30/2024
5:33 PM | Nurix Therapeutics (Issuer)
van Houte Hans (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/12/2024
4:10 PM | Nurix Therapeutics (Filer)
| Form 424B5 | |
04/12/2024
4:12 PM | Nurix Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/11/2024
3:06 PM | Nurix Therapeutics (Filer)
| Form 424B5 | |
04/10/2024
6:02 AM | Nurix Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/10/2024
6:06 AM | Nurix Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
04/09/2024
12:17 PM | Nurix Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/27/2024
6:01 AM | Nurix Therapeutics (Filer)
| Form DEF 14A | |
03/27/2024
6:02 AM | Nurix Therapeutics (Filer)
| Form DEFA14A | |
03/27/2024
6:03 AM | Nurix Therapeutics (Filer)
| Form ARS | |
03/11/2024
6:02 AM | Nurix Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/16/2024
6:20 PM | Nurix Therapeutics (Issuer)
van Houte Hans (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/16/2024
3:22 PM | Nurix Therapeutics (Subject)
van Houte Hans (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/15/2024
3:51 PM | Nurix Therapeutics (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
02/15/2024
6:22 AM | Nurix Therapeutics (Issuer)
SANDS ARTHUR T (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/15/2024
6:23 AM | Hansen Gwenn (Reporting)
Nurix Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/15/2024
6:23 AM | Nurix Therapeutics (Issuer)
Ring Christine (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/15/2024
6:23 AM | Nurix Therapeutics (Issuer)
van Houte Hans (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/14/2024
7:51 AM | Deep Track Capital, LP (Filed by)
Nurix Therapeutics (Subject)
| Form SC 13G/A | |
02/14/2024
7:00 AM | Nurix Therapeutics (Subject)
SANDS ARTHUR T (Filed by)
| Form SC 13G | |
02/09/2024
12:47 PM | MORGAN STANLEY (Filed by)
Nurix Therapeutics (Subject)
| Form SC 13G | |
02/09/2024
12:56 PM | Nurix Therapeutics (Subject)
WASATCH ADVISORS LP (Filed by)
| Form SC 13G/A | |
01/30/2024
5:52 PM | Nurix Therapeutics (Issuer)
Ring Christine (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/30/2024
5:52 PM | Hansen Gwenn (Reporting)
Nurix Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/30/2024
5:53 PM | Nurix Therapeutics (Issuer)
van Houte Hans (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/29/2024
3:00 PM | ARK Investment Management LLC (Filed by)
Nurix Therapeutics (Subject)
| Form SC 13G | |
01/24/2024
1:27 PM | BlackRock Inc. (Filed by)
Nurix Therapeutics (Subject)
| Form SC 13G/A | |
01/23/2024
9:28 AM | Nurix Therapeutics (Subject)
STATE STREET CORP (Filed by)
| Form SC 13G/A | |
01/08/2024
6:03 AM | Nurix Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/21/2023
4:19 PM | Nurix Therapeutics (Issuer)
van Houte Hans (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/20/2023
3:55 PM | Nurix Therapeutics (Issuer)
van Houte Hans (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/11/2023
11:03 AM | Nurix Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
Free NRIX Stock Alerts